» Articles » PMID: 22553520

Clinical Presentation of Retinoblastoma in Malaysia: a Review of 64 Patients

Overview
Specialty Ophthalmology
Date 2012 May 4
PMID 22553520
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To analyze the demography, presenting clinical features, spread of the disease of retinoblastoma in patients who were treated in two tertiary hospitals in Malaysia.

Methods: In this retrospective study, information of gender, age, race, presenting clinical features, findings of CT scan orbits and brain, lumbar puncture and bone marrow aspiration results were collected from the medical records of retinoblastoma patients diagnosed in Hospital of Universiti Sains Malaysia and General Hospital of Kuala Lumpur over a period of ten years. The data were collected in the same type of proforma from both hospitals.

Results: A total of 64 patients were treated in both hospitals together, of whom boys and girls were almost equally affected. The mean age of children at presentation was 24.2 (range 3-84) months, 53 (82.8%) children were under 36 months old. The disease was unilateral in 39 (60.9%) patients. The most common presenting signs were leukocoria in 46 (71.8%), followed by proptosis in 21 (32.8%) patients. Routine screening of the siblings of affected children revealed retinoblastoma in 2 patients. There was intracranial extension in 8 (12.5%) and metastasis in bone marrow in 6 (9.3%) patients.

Conclusion: Leukocoria is the most common presentation of retinoblastoma in Malaysia. However, the disease was intraocular in 40 (62.5%) and extraocular (orbital involvement, intracranial and distant metastasis) in 24 (37.5%) patients.

Citing Articles

Epidemiological and Clinical Presentation of Retinoblastoma among Nepalese Children in 2019.

Limbu B, Arjyal Kafle P, Lamichanne D, Pant S, Shakya S, Rasaily S South Asian J Cancer. 2023; 12(2):199-205.

PMID: 37969676 PMC: 10635776. DOI: 10.1055/s-0042-1757581.


Clinicopathological Presentation of Retinoblastoma in Ethiopia.

Sherief S, Mulatu D, Wu F, OBanion J, Dimaras H Ocul Oncol Pathol. 2023; 8(3):168-174.

PMID: 36938376 PMC: 10015587. DOI: 10.1159/000525113.


Different Types of Clinical Presentations and Stages of Retinoblastoma Among Children.

Moeez Uddin M, Farooque U, Aziz M, Yasmin F, Qureshi F, Saeed Y Cureus. 2020; 12(9):e10672.

PMID: 33133838 PMC: 7592547. DOI: 10.7759/cureus.10672.


Intra-arterial chemotherapy for retinoblastoma: Our first three-and-a-half years' experience in Malaysia.

Liu C, Mohmood A, Hamzah N, Lau J, Khaliddin N, Rahmat J PLoS One. 2020; 15(5):e0232249.

PMID: 32357178 PMC: 7194412. DOI: 10.1371/journal.pone.0232249.


Clinicopathological Findings of Retinoblastoma: A 10-Year Experience from a Tertiary Hospital in Kampala, Uganda.

Yahaya J, Rugwizangoga B, Mremi A, Munema A J Ophthalmol. 2019; 2019:5829284.

PMID: 31316824 PMC: 6604297. DOI: 10.1155/2019/5829284.


References
1.
Abramson D, Schefler A . Update on retinoblastoma. Retina. 2004; 24(6):828-48. DOI: 10.1097/00006982-200412000-00002. View

2.
Abramson D, FRANK C, Susman M, Whalen M, Dunkel I, Boyd 3rd N . Presenting signs of retinoblastoma. J Pediatr. 1998; 132(3 Pt 1):505-8. DOI: 10.1016/s0022-3476(98)70028-9. View

3.
Chang C, Chiou T, Hwang B, Bai L, Hsu W, Hsieh Y . Retinoblastoma in Taiwan: survival rate and prognostic factors. Jpn J Ophthalmol. 2006; 50(3):242-9. DOI: 10.1007/s10384-005-0320-y. View

4.
Chung S, Sa H, Koo H, Yoo K, Sung K, Ham D . Clinical manifestations and treatment of retinoblastoma in Korea. Br J Ophthalmol. 2008; 92(9):1180-4. DOI: 10.1136/bjo.2008.140046. View

5.
Tan N, Balakrishnan V, Ling Y . Retinoblastoma in Singapore: 1976 to 1995. Ann Acad Med Singap. 1997; 26(2):154-60. View